Skip to main content

Table 4 Maximum toxicity grade in patients treated with TPF versus PF after matching

From: Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis

Adverse event

PF group [cases (%)]

TPF group [cases (%)]

P value

Grade 0–2

Grade 3–4

Grade 0–2

Grade 3–4

Neutropenia

207 (70.4)

87 (29.6)

176 (59.9)

118 (40.1)

0.009

Anemia

275 (93.5)

19 (6.5)

286 (97.3)

8 (2.7)

0.047

Thrombocytopenia

268 (91.2)

26 (8.8)

284 (96.6)

10 (3.4)

0.009

Liver injury

291 (99.0)

3 (1.0)

292 (99.3)

2 (0.7)

1.000

Kidney injury

294 (100)

0 (0)

294 (100)

0 (0)

1.000

Nausea/vomiting

114 (38.8)

180 (61.2)

151 (51.4)

143 (48.6)

0.003

Any of the above

109 (37.0)

185 (63.0)

83 (28.2)

211 (71.8)

0.028

  1. TPF taxane, cisplatin and 5-fluorouracil, PF cisplatin and 5-fluorouracil. Adverse events were graded according to the National Cancer Institute Common Toxicity Criteria, version 4.0